Key Financial Data Of Reporting Company

Immuno-Biological Laboratories Co., Ltd. - Filing #7244299

Concept As at
2025-03-31
As at
2025-03-31
As at
2025-03-31
2024-04-01 to
2025-03-31
As at
2025-03-31
2024-04-01 to
2025-03-31
2023-04-01 to
2024-03-31
2023-04-01 to
2024-03-31
As at
2024-03-31
As at
2024-03-31
2022-04-01 to
2023-03-31
As at
2023-03-31
As at
2023-03-31
2022-04-01 to
2023-03-31
2021-04-01 to
2022-03-31
2021-04-01 to
2022-03-31
As at
2022-03-31
As at
2022-03-31
As at
2021-03-31
2020-04-01 to
2021-03-31
2020-04-01 to
2021-03-31
As at
2021-03-31
Key financial data of reporting company
Business results of reporting company
Net sales
969,533,000 JPY
959,658,000 JPY
812,850,000 JPY
816,701,000 JPY
790,600,000 JPY
794,621,000 JPY
603,855,000 JPY
647,576,000 JPY
531,820,000 JPY
602,749,000 JPY
Ordinary profit (loss)
209,861,000 JPY
219,847,000 JPY
145,815,000 JPY
125,413,000 JPY
65,973,000 JPY
-149,503,000 JPY
-69,963,000 JPY
-243,472,000 JPY
-196,675,000 JPY
-310,511,000 JPY
Profit (loss)
249,047,000 JPY
186,694,000 JPY
-630,968,000 JPY
-123,641,000 JPY
-219,107,000 JPY
Share capital
50,000,000 JPY
50,000,000 JPY
3,029,041,000 JPY
3,029,041,000 JPY
3,029,041,000 JPY
Total number of issued shares
9,314,590 xbrli:shares
9,314,590 xbrli:shares
9,314,590 xbrli:shares
9,314,590 xbrli:shares
9,314,590 xbrli:shares
Net assets
1,514,358,000 JPY
1,524,158,000 JPY
1,265,311,000 JPY
1,275,111,000 JPY
1,088,416,000 JPY
1,078,616,000 JPY
1,368,348,000 JPY
1,719,385,000 JPY
1,629,282,000 JPY
1,845,193,000 JPY
Total assets
1,845,390,000 JPY
1,812,359,000 JPY
1,618,582,000 JPY
1,585,218,000 JPY
1,394,501,000 JPY
1,434,337,000 JPY
1,705,338,000 JPY
1,997,942,000 JPY
1,838,038,000 JPY
1,962,901,000 JPY
Net assets per share
162.60
163.65
135.85
136.91
116.86
115.81
146.92
184.61
174.70
197.88
Dividend paid per share
Interim dividend paid per share
Basic earnings (loss) per share
26.74
26.74
20.05
20.05
-67.74
-31.10
-13.27
-27.78
-23.52
-34.23
Diluted earnings per share
Equity-to-asset ratio
0.821 xbrli:pure
0.841 xbrli:pure
0.782 xbrli:pure
0.804 xbrli:pure
0.781 xbrli:pure
0.752 xbrli:pure
0.802 xbrli:pure
0.861 xbrli:pure
0.885 xbrli:pure
0.939 xbrli:pure
Rate of return on equity
0.179 xbrli:pure
0.178 xbrli:pure
0.158 xbrli:pure
0.159 xbrli:pure
xbrli:pure
xbrli:pure
xbrli:pure
xbrli:pure
xbrli:pure
xbrli:pure
Price-earnings ratio
18.0 xbrli:pure
18.0 xbrli:pure
26.4 xbrli:pure
26.4 xbrli:pure
xbrli:pure
xbrli:pure
xbrli:pure
xbrli:pure
xbrli:pure
xbrli:pure
Payout ratio
xbrli:pure
xbrli:pure
xbrli:pure
xbrli:pure
xbrli:pure
Net cash provided by (used in) operating activities
183,495,000 JPY
133,775,000 JPY
26,458,000 JPY
-93,204,000 JPY
-194,145,000 JPY
Net cash provided by (used in) investing activities
-53,660,000 JPY
-24,496,000 JPY
30,036,000 JPY
-155,629,000 JPY
-17,233,000 JPY
Net cash provided by (used in) financing activities
-31,755,000 JPY
991,000 JPY
991,000 JPY
143,998,000 JPY
-216,000,000 JPY
Cash and cash equivalents
770,563,000 JPY
674,969,000 JPY
561,997,000 JPY
449,184,000 JPY
552,022,000 JPY
Number of employees
58 xbrli:pure
58 xbrli:pure
58 xbrli:pure
58 xbrli:pure
57 xbrli:pure
57 xbrli:pure
59 xbrli:pure
60 xbrli:pure
63 xbrli:pure
62 xbrli:pure
65 xbrli:pure
58 xbrli:pure
Average number of temporary employees
5 xbrli:pure
5 xbrli:pure
5 xbrli:pure
5 xbrli:pure
5 xbrli:pure
5 xbrli:pure
8 xbrli:pure
8 xbrli:pure
7 xbrli:pure
7 xbrli:pure
9 xbrli:pure
7 xbrli:pure
Total shareholder return
0.8939 xbrli:pure
0.9851 xbrli:pure
0.7579 xbrli:pure
0.6089 xbrli:pure
1.0279 xbrli:pure
Total return on share price index
3.2975 xbrli:pure
3.3493 xbrli:pure
2.3697 xbrli:pure
2.2395 xbrli:pure
2.1959 xbrli:pure

Talk to a Data Expert

Have a question? We'll get back to you promptly.